Si-Bone’s new CCO is ex-Baxano CEO Recupero Si-Bone said yesterday it tapped ex-Baxano (NSDQ:BAXS) CEO Tony Recupero as its new chief commercial officer. Prior to moving to Si-Bone, Recupero served as president of medical device and diganostic commercialization strategy company Catalyst Performance Advisors and CEO of Baxano Inc, as well as other executive positions in the […]
Baxano Surgical files for bankruptcy, CFO steps down
TriVascular Tech recall of stent grafts may drag down full-year revenues | Medtech Wall Street news for the week of September 22, 2014
TriVascular Tech's stent graft recall could hurt the bottom line
September 19, 2014 by Arezu Sarvestani
Baxano puts itself on the auction block
FTC wants more data on MDT-COV deal | Medtech Wall Street news for the week of August 11, 2014
Baxano: Strong Q2, new patents can’t appease Wall Street
Baxano Surgical (NSDQ:BAXS) just can’t seem to do right by Wall Street.
ForSight Vision5 pulls down a $15 million Series C round | Medtech funding stories for the week of Apr. 21, 2014
Spine: Baxano Surgical closes $10M private placement
SafeStitch lures Baxano CFO Slattery to be new finance chief
Baxano lowers full-year guidance amid widening losses, growing sales
Baxano Surgical pays $6M to settle federal healthcare fraud beef
- 1
- 2
- 3
- 4
- Next Page »
